Needham: Reiterates Intra-Cellular Therapies (ITCI.US) buy rating with a target price of $90.00.
Needham:重申Intra-Cellular Therapies(ITCI.US)买入评级, 目标价90.00美元。
Needham: Reiterates Intra-Cellular Therapies (ITCI.US) buy rating with a target price of $90.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.